Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease.

@article{Adams2007RoleOL,
  title={Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease.},
  author={Leon Anton Adams and Paul Angulo},
  journal={Clinics in liver disease},
  year={2007},
  volume={11 1},
  pages={25-35, viii}
}
Non-alcoholic fatty liver disease (NAFLD) is common and may progress to end-stage liver disease. Liver-related morbidity and mortality occur almost exclusively in patients whose disease progresses to advanced fibrosis and cirrhosis. Presence and severity of liver fibrosis seem the most important indicators of long-term prognosis. Clinical and biochemical variables may help select NAFLD patients in whom liver biopsy may provide the most prognostic information. Some serum markers of liver… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 31 extracted citations

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease

Clinical and molecular hepatology • 2013
View 3 Excerpts
Highly Influenced

Non-alcoholic fatty liver disease: is iron relevant?

Hepatology international • 2012
View 9 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…